Scholar Rock is delivering muscle-targeted breakthroughs to transform the treatment of spinal muscular atrophy (SMA) and other rare neuromuscular diseases where muscle atrophy remains a critical unmet need.

As a global leader in myostatin biology, a field focused on proteins that regulate muscle mass, the biopharmaceutical company is named for the visual resemblance of a scholar rock to protein structures. Our commitment to unlock fundamentally different treatment approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. Scholar Rock works every day to create new possibilities for patients through its highly innovative anti-myostatin program, including opportunities in additional rare neuromuscular diseases. Learn more about our neuromuscular franchise at ScholarRock.com and follow @ScholarRock on X and on LinkedIn.

Summary of Position:

Reporting to the VP, Finance EMEA, the Associate Director/ Director, FP&A will support Scholar Rock’s EMEA organization. The successful candidate will bring a proven track record of planning and delivering against financial objectives in close partnership with cross-functional stakeholders.

In this role, they will serve as a strategic partner in framing, evaluating, and driving decisions to maximize value creation. Success will require clear communication, strong organization, and a collaborative mindset.

This position offers an opportunity to help build a critical cross-functional capability within a growing, evolving, multi-product candidate biotechnology company.

Serve as the primary finance partner for the EMEA scope across revenue and OPEX planning.

Support FP&A activities including budgeting and forecasting, long-range planning, scenario modeling, and financial analysis for strategic initiatives.

Build and maintain patient and revenue models, ensuring appropriate underlying assumptions for direct and partner markets.

Partner with EMEA Accounting on month-end and quarter-end close activities, quarterly schedules, procure-to-pay processes, and support for external reporting and audit inquiries.

Deliver timely monthly budget-to-actual analyses, including variance analysis and management reporting.

Drive continuous improvement of FP&A processes to increase efficiency while maintaining flexibility to meet evolving business needs.

Develop and deliver training and change-management support to drive adoption of new FP&A tools, systems, and ways of working across the organization.

Support ad hoc strategic initiatives as business needs arise, including business development analyses, partner support, portfolio prioritization, and financing strategies.

Bachelor’s degree and 8+ years of progressive finance experience in the pharmaceutical or biotechnology industry.

Advanced degree in science and/or business preferred.

Experience partnering with Commercial and/or Medical teams in a cross-functional environment.

Excellent presentation skills, with the ability to communicate effectively at all levels of the organization.

Strong partnering and communication skills, with the ability to translate complex financial information into clear, actionable insights.

Advanced Excel skills and the ability to conduct complex analyses to support key decisions.

Solid understanding of fundamental accounting principles.

Understanding of the drug development process from early research through product launch.

Strong organizational and problem-solving skills, with the ability to manage multiple projects simultaneously.

Experience with Adaptive Insights and/or SAP is an asset.

Fluency in English is required. Additional European languages are an asset.

Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.

Associate Director/ Director FP&A EMEA

Quick Summary

Location & Eligibility

Listing Details

Posting Health

4 other jobs at

Similar Associate jobs

Browse Similar Jobs

Stay ahead of the market